BSE filing, NSE: SHIVMED. Summary written from the filing by ALFA Finder's alert engine.
Bandaram Pharma Packtech Ltd: key numbers
- Share price
- ₹19.69
- Market cap
- ₹35.39 Cr
- Revenue (annual)
- ₹62.92 Cr
- Net profit (annual)
- ₹1.01 Cr
- P/E (TTM)
- 34.8×Sector 51.1×
- Promoter holding
- 62.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandaram Pharma Packtech Ltd
All →Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech will hold a board meeting on 29 October 2026 to consider September 2026 quarter results. The trading window stays closed until 16 November 2026.
Bandaram Pharma Packtech Other Announcement
Bandaram Pharma Packtech Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a standard periodic regulatory disclosure of the company's shareholding structure.
Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech submitted its Annual Report and notice for the AGM, which is now rescheduled for September 24, 2026.
Bandaram Pharma Packtech Management Change
Bandaram Pharma Packtech re-appointed its statutory auditor for 36 months and an independent director for a 60-month term, both approved in the board meeting.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.